Treatmment Bronchial Asthma Flashcards

(49 cards)

1
Q

Drug delivery

A

Topically to nasal mucosa
 Inhaled into lungs ( most effective)
 Orally
 Parenterally faster action
Local delivery methods preferred to minimize systemic side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Most used drug for asthma

A

1-sympathomimetic agents (used as “relievers” or
bronchodilators)
2-inhaled corticosteroids (used as “controllers” or anti-
inflammatory agents)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Anticholinergics

A

Ipratropium, tiotropium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Methylxanthines

A

Theophylline, aminophylline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Monoclonal antibodies

A

Omalizumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

 Mast cell stabilizers

A

Sodium cromoglycate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Leukotriene inhibitors

A

Zileuton, montelukast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

β2-adrenergic agonists

A

β2-adrenergic agonists relax airway smooth muscle,
quick relief

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

β2 agonists have inflammatory effect true /false ¿

A

False • β2 agonists have no anti-inflammatory effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

β2 agonists • not be used as monotherapy for patients with persistent asthma

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Short-acting β2 agonists:

A

a rapid onset of action (5-15min)

best delivered by inhalation

local effect on airway smooth muscle with least systemic
toxicity 80–90% of total dose of aerosol is deposited in the
mouth or pharynx

symptomatic treatment of bronchospasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Chronic use of β2-agonists - leads to tachyphylaxis
due to receptor down regulation

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Adverse effect of short b2 agonists

A

tachycardia, hyperglycemia, hypokalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Example for short b2agnists

A

Salbutamol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Example for Long-acting β2 agonists

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Duration of Long-acting β2 agonists

A

ong duration of action (12 hours)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Long acting used for acute attack ¿

A

False  should NOT be used for acute attack

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Long acting used only in combination with an asthma controller
medication

A

ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Example for Ultra LABA

A

vilanterol) has a 24-hour bronchodilator duration
of effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Vilanterol combian ……….for daily asthma

21
Q

Mechanism of Action Corticosteroids

A

inhibit arachidonic acid by phospholipase A2 inhibition
 producing anti-inflammatory effect

22
Q

Inhalational route ICS most commonly used ¿

23
Q

ICSs
Examples-

A

Beclomethasone, budesonide, fluticasone

24
Q

Systemic corticosteroids indicated in acute severe
asthma

A

prednisone/ prednisolone

25
Adverse effects and cautions Corticosteroids
Sudden discontinuation of oral/parenteral therapy  acute adrenal insufficiency --- can be fatal
26
When the Systemic adverse effects may occur Corticosteroids
high dose ICSs
27
Where the ICS deposit
oral and laryngeal mucosa
28
Corticosteroids  can cause candidiasis and dysphonia
True Prevented by rinsing mouth with water, use of spacer
29
Ciclesonide associated with less frequent candidiasis
True
30
Zafirlukast Food impairs absorptio
True
31
Zileuton and its metabolites excreted in urine
True
32
Zafirlukast, montelukast, and metabolites liver
False Zafirlukast, montelukast, and metabolites undergo biliary excretion
33
Not useful in an acute asthma attack, because it is not a bronchodilator
Cromolyn sodium
34
alternative therapy for mild persistent asthma prophylactic anti-inflammatory agent
Cromolyn sodium
35
Ipratropium
nonselective M1, M2, and M3 antagonist  poorly absorbed, minimal systemic effects  adjunctive therapy in acute severe asthma not completely responsive to β2-agonists  not recommended for routine treatment of acute asthma  onset is much slower than inhaled SABAs  multiple-dose ipratropium bromide added to initial therapy in moderate to severe asthma
36
Tiotropium
long-acting anticholinergic agent  can be used as an add-on treatment in severe asthma Adverse effects  Xerostomia
37
Mechanism of Action Anticholinergics
Muscarinic antagonists reverse cholinergic bronchoconstriction  block vagally mediated contraction of airway smooth muscle and mucus secretion
38
X use has declined  high risk of severe toxicity  drug interactions  less efficacy compared with ICSs and LABAs
Methyl Xanthines
39
Nonselective phosphodiesterase inhibition  They also inhibit adenosine receptors ( adenosine contracts airways)
Theophylline
40
Theophylline Toxicities include
nausea, vomiting  tachycardia, cardiac arrhythmias  Monitoring of serum concentrations essential for safe use • narrow therapeutic index • Dose of theophylline should be decreased if enzyme inhibitors like erythromycin and Ciprofloxacin are prescribed with it
41
Binds selectively to (IgE)
Omalizumab
42
Omalizumab monoclonal antibody
True
43
Decreases binding of IgE to its receptor on mast cells and basophils.
Omalizumab
44
 Is indicated for treatment of moderate to severe persistent asthma in poorly controlled patients
Omalizumab
45
Route of administration (subcutaneous)
Omalizumab
46
Drugs used in treatment COPD
1. Inhaled β2-agonists 2. Anticholinergic agents  ipratropium and tiotropium 3. Inhaled corticosteroids 4. Other agents  Roflumilast  Oral phosphodiesterase-4 inhibitor  Not indicated for relief of acute bronchospasm
47
Two types of aerosols can be used.
• Aerosol using drugs in solution: These include metered dose inhaler(MDI) and nebulizers • Aerosols using drugs as dry powder (DPI)
48
Spacers
large-volume chamber attached to an MDI more likely to reach the target airway tissue
49
Delivers beta-adrenergic drugs directly to the lungs This is inhaled without having to coordinate dosing with breathing sound waves to create a continuous mist of drug
Nebulizer